Annual Accounts Receivable
N/A
December 31, 2023
Summary
- ACHV annual accounts receivable is not available.
Performance
ACHV Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- ACHV quarterly accounts receivable is not available.
Performance
ACHV Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ACHV Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ACHV Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Achieve Life Sciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2018 | $7000.00(-22.2%) | $7000.00(-72.0%) |
| Sep 2018 | - | $25.00 K(-79.8%) |
| Jun 2018 | - | $124.00 K(+1671.4%) |
| Mar 2018 | - | $7000.00(-22.2%) |
| Dec 2017 | $9000.00(-35.7%) | $9000.00(-87.1%) |
| Sep 2017 | - | $70.00 K(-71.0%) |
| Jun 2017 | - | $241.00 K(+1.7%) |
| Mar 2017 | - | $237.00 K(+1592.9%) |
| Dec 2015 | $14.00 K(-99.8%) | $14.00 K(+7.7%) |
| Sep 2015 | - | $13.00 K(-91.3%) |
| Jun 2015 | - | $149.00 K(-90.4%) |
| Mar 2015 | - | $1.56 M(-72.5%) |
| Dec 2014 | $5.68 M(-34.4%) | $5.68 M(+17.6%) |
| Sep 2014 | - | $4.83 M(-2.5%) |
| Jun 2014 | - | $4.95 M(-42.5%) |
| Mar 2014 | - | $8.61 M(-0.5%) |
| Dec 2013 | $8.66 M(+1112.5%) | $8.66 M(-12.7%) |
| Sep 2013 | - | $9.92 M(+54.1%) |
| Jun 2013 | - | $6.44 M(+24.9%) |
| Mar 2013 | - | $5.16 M(+622.1%) |
| Dec 2012 | $714.00 K | $714.00 K(-37.3%) |
| Sep 2012 | - | $1.14 M(+19.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $956.00 K(+23.5%) |
| Mar 2012 | - | $774.00 K(+72.4%) |
| Dec 2011 | $449.00 K(-63.3%) | $449.00 K(-54.5%) |
| Sep 2011 | - | $987.00 K(-34.1%) |
| Jun 2011 | - | $1.50 M(+11.1%) |
| Mar 2011 | - | $1.35 M(+10.1%) |
| Dec 2010 | $1.22 M(-60.6%) | $1.22 M(-66.0%) |
| Sep 2010 | - | $3.60 M(+770.5%) |
| Jun 2010 | - | $413.00 K(-85.4%) |
| Mar 2010 | - | $2.82 M(-9.2%) |
| Dec 2009 | $3.11 M(+1932.0%) | $3.11 M(>+9900.0%) |
| Sep 2009 | - | $31.00 K(+3.3%) |
| Jun 2009 | - | $30.00 K(-78.4%) |
| Mar 2009 | - | $139.00 K(-9.2%) |
| Dec 2008 | $153.00 K(-98.1%) | $153.00 K(-4.4%) |
| Sep 2008 | - | $160.00 K(-96.5%) |
| Sep 2007 | - | $4.58 M(-17.5%) |
| Jun 2007 | - | $5.55 M(-32.1%) |
| Mar 2007 | - | $8.17 M(+1.6%) |
| Dec 2006 | $8.04 M(+14.0%) | $8.04 M(-16.8%) |
| Sep 2006 | - | $9.67 M(-0.2%) |
| Jun 2006 | - | $9.69 M(+178.9%) |
| Mar 2006 | - | $3.47 M(-50.8%) |
| Dec 2005 | $7.06 M | $7.06 M |
FAQ
- What is the all time high annual accounts receivable for Achieve Life Sciences?
- What is the all time high quarterly accounts receivable for Achieve Life Sciences?
What is the all time high annual accounts receivable for Achieve Life Sciences?
Achieve Life Sciences all-time high annual accounts receivable is $8.66 M
What is the all time high quarterly accounts receivable for Achieve Life Sciences?
Achieve Life Sciences all-time high quarterly accounts receivable is $9.92 M